PortfoliosLab logo

Capricor Therapeutics, Inc. (CAPR)

Equity · Currency in USD · Last updated Jun 18, 2022

Company Info

ISINUS14070B3096
CUSIP14070B309
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$4.27
Year Range$2.83 - $5.68
EMA (50)$3.64
EMA (200)$3.84
Average Volume$103.05K
Market Capitalization$103.86M

CAPRShare Price Chart


Chart placeholderClick Calculate to get results

CAPRPerformance

The chart shows the growth of $10,000 invested in Capricor Therapeutics, Inc. on Jan 6, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $72 for a total return of roughly -99.28%. All prices are adjusted for splits and dividends.


CAPR (Capricor Therapeutics, Inc.)
Benchmark (^GSPC)

CAPRReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M35.56%-10.13%
YTD45.73%-22.90%
6M33.02%-21.29%
1Y-2.95%-12.99%
5Y-9.41%8.60%
10Y-25.81%10.05%

CAPRMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

CAPRSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Capricor Therapeutics, Inc. Sharpe ratio is -0.25. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


CAPR (Capricor Therapeutics, Inc.)
Benchmark (^GSPC)

CAPRDividend History


Capricor Therapeutics, Inc. doesn't pay dividends

CAPRDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


CAPR (Capricor Therapeutics, Inc.)
Benchmark (^GSPC)

CAPRWorst Drawdowns

The table below shows the maximum drawdowns of the Capricor Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Capricor Therapeutics, Inc. is 99.85%, recorded on Mar 10, 2020. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.85%Jan 7, 20102509Mar 10, 2020

CAPRVolatility Chart

Current Capricor Therapeutics, Inc. volatility is 76.71%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


CAPR (Capricor Therapeutics, Inc.)
Benchmark (^GSPC)

Portfolios with Capricor Therapeutics, Inc.


Loading data...